BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 8, 2026
Home
»
Topics
» Regulatory
Regulatory
RSS
FDA approves Tibotec's Intelence 200-mg formulation
Jan. 4, 2011
FDA approves Amturnide, a triple-combination pill, to treat high blood pressure
Dec. 24, 2010
European approval of Brilique for prevention of atherothrombotic events
Dec. 10, 2010
FDA approves Vyvanse for ADHD in adolescents
Nov. 17, 2010
FDA approves Egrifta for lipodystrophy in HIV-infected patients
Nov. 12, 2010
FDA approves once-daily Kombiglyze XR tablets for type 2 diabetes
Nov. 8, 2010
Questcor Pharma's Acthar launched in U.S. for infantile spasms
Nov. 5, 2010
FDA approves Teflaro for CABP and ABSSSI in adults
Nov. 4, 2010
FDA approves Avanir's Nuedexta for treatment of pseudobulbar affect
Nov. 2, 2010
Sunovion receives FDA approval for its once-daily schizophrenia treatment Latuda
Oct. 29, 2010
Previous
1
2
…
1071
1072
1073
1074
1075
1076
1077
1078
1079
…
1355
1356
Next
RSS